TCM
ALBO

Tekla Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Tekla Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-105,154
Closed -$3.39M – 203
2019
Q2 		$3.39M Sell
105,154
-19,846
-16% -$664K 0.14% 112
2019
Q1 		$4.03M Hold
125,000
– – 0.16% 107
2018
Q4 		$3.07M Hold
125,000
– – 0.13% 108
2018
Q3 		$4.12M Hold
125,000
– – 0.15% 106
2018
Q2 		$4.44M Hold
125,000
– – 0.17% 99
2018
Q1 		$4.07M Buy
+125,000
New +$4.21M 0.16% 100

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Tekla Capital Management's ALBO Position: Q3 2019 in Review

Tekla Capital Management sold out of Albireo Pharma Inc (ALBO) in Q3 2019, closing a stake of 105,154 shares — an estimated $3.39M sold.

Tekla Capital Management first reported a position in ALBO in Q1 2018 and held it in 6 quarters. The position peaked at $4.44M in Q2 2018. 69 funds tracked by Wall St. Rank hold ALBO as of Q3 2019.

  • Tekla Capital Management reported no remaining Albireo Pharma Inc position as of Q3 2019 after selling out during the quarter.
  • Tekla Capital Management sold 105,154 Albireo Pharma Inc shares in Q3 2019, an estimated $3.39M.
  • Tekla Capital Management first reported a position in Albireo Pharma Inc in Q1 2018 and held it in 6 quarters.
  • Tekla Capital Management's Albireo Pharma Inc position peaked at $4.44M in Q2 2018.
  • 69 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2019.

Based on Tekla Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.